2004
DOI: 10.1099/vir.0.79949-0
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats

Abstract: In a previous vaccination study in cats, the authors reported on accelerated feline immunodeficiency virus (FIV) replication upon challenge in animals vaccinated with a candidate envelope subunit vaccine. Plasma transfer studies as well as antibody profiles in vaccinated cats indicated a causative role for antibodies directed against the hypervariable regions HV3, HV4 and HV5 (HV3–5) of the envelope glycoprotein. The present study was designed to investigate further the contribution of antibodies in envelope v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 53 publications
0
6
0
Order By: Relevance
“…Although we have no evidence that the effect observed is relevant in vivo, an enhancing or accelerating effect on FIV replication has been described for several situations, including vaccine experiments using immunogens of varied complexity, in which the factors responsible have most often eluded a clear identification (18,21,24,28,45,51). The enhancing effect described here was instead clearly characterized as mediated by the antibodies generated by lipo-P59, since it was reproduced by IgG and Fab purified from the sera and was ablated by preadsorption with lipo-P59.…”
Section: Discussionmentioning
confidence: 92%
“…Although we have no evidence that the effect observed is relevant in vivo, an enhancing or accelerating effect on FIV replication has been described for several situations, including vaccine experiments using immunogens of varied complexity, in which the factors responsible have most often eluded a clear identification (18,21,24,28,45,51). The enhancing effect described here was instead clearly characterized as mediated by the antibodies generated by lipo-P59, since it was reproduced by IgG and Fab purified from the sera and was ablated by preadsorption with lipo-P59.…”
Section: Discussionmentioning
confidence: 92%
“…In particular antibodies to the V3-V6 regions of the envelope protein were associated with the observed enhancement of infection. In a follow-up study, recombinant envelope protein was prepared from which the part encompassing the region between V3 and V6 was deleted [98]. Vaccination with this engineered protein still predisposed for increased susceptibility to infection and it was concluded that also antibodies directed to epitopes outside the V3-V6 region were able to cause enhancement of infection.…”
Section: Fiv Vaccine Candidatesmentioning
confidence: 99%
“…Intriguingly, using a T cell based neutralization assay based on MBM cells (an IL2-dependent cell line similar to MYA-1 cells [88]), the sera from the immunized cats were found to enhance FIV infection, an effect that could be adsorbed by pre-incubation with lipo-P59 [87]. While disappointing from a vaccine design perspective, these findings may prove informative in interpreting why some FIV vaccines that failed to induce protective immunity, appeared to enhance infection following challenge [62,69,89–93]. …”
Section: Fiv Neutralizing Antibodiesmentioning
confidence: 99%